Imagine a healthcare approach where treatments are as unique as the individuals they serve—the smart test for the smart drug. It’s a concept that’s revolutionising patient care yet has not been adopted. Why is personalised medicine not the norm, and what steps are needed to make it accessible everywhere?
In this episode of Clinical Trials & Tribulations, hosted by John Emmerson and Matt Britland and featuring an esteemed panel of experts, we aim to uncover these critical questions. We’ll shine a spotlight on the pivotal role of biomarkers in clinical trials, particularly in cardiovascular and oncology research. This webinar isn’t just about theory; it’s a practical exploration.
